Abstract:INTRODUCTIONS:Osteoarthritis (OA) is a significant contributor to disability in the elderly population. However, current therapeutic options are limited. The transient receptor potential melastatin 2 (TRPM2) is involved in a range of disease processes, yet its role in OA remains unclear. OBJECTIVES:To investigate the role of TRPM2 in OA. METHODS:Cartilage samples were collected from patients with osteoarthritis (OA) and mice with OA to examine TRPM2 expression levels. To investigate the effects of TRPM2 modulation on the destabilization of the medial meniscus (DMM) induced knee OA in mice, we utilized TRPM2 knockout mice and employed adenovirus-mediated overexpression of TRPM2. Furthermore, siRNA-mediated TRPM2 knockdown or plasmid-mediated TRPM2 overexpression was conducted to explore the role of TRPM2 in IL-1β-induced chondrocytes. The regulatory mechanism of IL-1β on TRPM2 expression was screened by signaling pathway inhibitors, and the transcription factors and binding sites of TRPM2 were predicted using the database. The binding of RELA (NF-κB-p65) to the Trpm2 promoter was verified by chip-PCR and ChIP-qPCR. The therapeutic potential of Ca2+ chelation with BAPTA-AM for the treatment of osteoarthritis (OA) was investigated. RESULTS:An increased expression of TRPM2 was observed in the cartilage of OA patients and OA mice. Furthermore, mice deficient in Trpm2 exhibited a protective effect against DMM-induced OA progression. In contrast, TRPM2 overexpression resulted in exacerbation of DMM-induced OA and thepromotion of an OA-like phenotype of chondrocytes. TRPM2 was upregulated by IL-1β in an NF-κB-p65-dependent manner. Subsequently, the TRPM2-Ca2+-mtDNA-cGAS-STING-NF-κB axis in the progression of OA was validated. Furthermore, inhibition of the TRPM2-Ca2+ axis with BAPTA-AM effectively attenuated established OA. CONCLUSIONS:Our data collectively revealed a pathological feedback loop involving TRPM2, Ca2+, mtDNA, cGAS, STING, and NF-κB in OA chondrocytes. This suggests that disrupting this loop could be a viable therapeutic approach for OA.

TRPV Channels in Osteoarthritis: A Comprehensive Review

TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+/CaMKII/Nrf2 signaling pathway

The role of TRPV1 in RA pathogenesis: worthy of attention

Targeting the TRPV1 pain pathway in osteoarthritis of the knee

The role of Th/Treg immune cells in osteoarthritis

TRPV4-mediated mitochondrial dysfunction induces pyroptosis and cartilage degradation in osteoarthritis via the Drp1-HK2 axis

TRPM2-mediated Feed-Forward Loop Promotes Chondrocyte Damage in Osteoarthritis Via Calcium-Cgas-sting-nf-κb Pathway

TRPV4 Channel in Neurological Disease: from Molecular Mechanisms to Therapeutic Potential

Current understanding of osteoarthritis pathogenesis and relevant new approaches

Transient Receptor Potential (TRP) Ion Channels in Orofacial Pain

The Role of Mechanically-Activated Ion Channels Piezo1, Piezo2, and TRPV4 in Chondrocyte Mechanotransduction and Mechano-Therapeutics for Osteoarthritis

Effect of Cell Receptors in the Pathogenesis of Osteoarthritis: Current Insights

Blocking TRPV4 Ameliorates Osteoarthritis by Inhibiting M1 Macrophage Polarization via the ROS/NLRP3 Signaling Pathway

Inflammation—the role of TRPA1 channel

Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues

Estrogen-related receptors: novel potential regulators of osteoarthritis pathogenesis

THE RICHMOND MEETING OF THE AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE AND ASSOCIATED SOCIETIES.

Alterations in the microenvironment and the effects produced of TRPV5 in osteoporosis

Regulation of pain neurotransmitters and chondrocytes metabolism mediated by voltage-gated ion channels: A narrative review

Neural and immune roles in osteoarthritis pain: Mechanisms and intervention strategies

Bifunctional TRPV1 Targeted Magnetothermal Switch to Attenuate Osteoarthritis Progression